AceView offers a comprehensive annotation of human, mouse and nematode genes
reconstructed by co-alignment and clustering of all publicly available
mRNAs and ESTs on the genome sequence. Our goals are to offer a reliable
up-to-date resource on the genes, their functions, alternative variants,
expression, regulation and interactions, in the hope to stimulate
further validating experiments at the bench
This site normally requires a frame enabled viewer,
However, click here to access our full description of gene ALDH2.
, go to our main page or see our latest news
Homo sapiens gene ALDH2, encoding aldehyde dehydrogenase 2 family (mitochondrial).
TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Compact gene diagram
Alternative mRNAs are shown aligned from 5' to 3' on a virtual genome where introns have been shrunk to a minimal length. Exon size is proportional to length, intron height reflects the number of cDNAs supporting each intron. Introns of the same color are identical, of different colors are different. 'Good proteins' are pink, partial or not-good proteins are yellow, uORFs are green. 5' cap or3' poly A flags show completeness of the transcript.
Read more...
Mouse over the ending of each transcript gives tissues from which the supporting cDNAs were extracted. Details on tissue of origin for each intron and exon is available from the
intron and exons table.
Click on any transcript to open the specific mRNA page, to see the exact cDNA clone support and eventual SNPs and to get details on tissues, sequences, mRNA and protein annotations. Proteins supported by a single continuous cDNA sequence lead to underlining the name/ending of the variant. Names not underlined result from cDNA concatenation in the coding region and should be experimentally checked.
Introns are depicted by broken lines; the height of the top of each intron reflects the relative number of clones supporting this intron.
]^[ A pink broken line denotes an intron with standard boundaries (gt-ag or gc-ag) that is exactly supported (i.e. a cDNA sequence exactly matches the genome over 16 bp, 8 on both sides of the intron).
] ^ ] A blue broken line denotes non-standard introns, exactly supported, but with non-standard at-ac or any other boundaries.
]-[ Pink and
] - ] blue straight lines represent 'fuzzy' introns of the standard and non-standard types respectively, those introns do not follow the 16 bp rule. Black straight lines ]-[denote gaps in the alignments.
Exons: Wide filled pink areas represent putative protein coding regions, narrow empty pink boxes represent the 5'UTR (on the left) and 3' UTR (on the right). Flags identify validated endings: cap site on the 5' side, polyadenylation site on the 3' side. Filled flags correspond to frequent events while empty flags have lesser supporting cDNAs (yet all are validated); at the 3' side, black flags are associated to the main AATAAA signal,
blue flags to any single letter variant of the main . More explanations are given in the
gene help file
Expression and GenBank cDNA support
Tissues where expression was observed (from 309 cDNA clones)
Origin of the cDNAs, as reported in GenBank/dbEST (tissue, stage, pathological or normal) shows that the gene is expressed in brain (seen 30 times), stomach (21), hypothalamus (18), liver (16), eye (15), lung (14), breast carcinoma (11), epidermis (11), colon (10), corresponding non cancerous liver tissue (9), kidney (8), neuroblastoma cells (8), placenta (8), placenta cot 25-normalized (8), head neck (7), testis (7), ascites (6), hepatocellular carcinoma, cell line (6), nervous normal (6), skin (6), fetal brain (5), fetal liver (5), neuroblastoma cot 10-normalized (5), optic nerve (5), pancreas (5), adult brain (4), cochlea (4), colon ins (4), ear (4), hippocampus (4), primary lung cystic fibrosis epithelialcells (4), B cells (ramos cell line) (3), carcinoid (3), germinal center B cell (3), heart (3), insulinoma (3), large cell carcinoma (3), nervous tumor (3), ovary (3), small intestine (3), uterus (3), adenocarcinoma (2), anaplastic oligodendroglioma (2), B cells from burkitt lymphoma (2), bladder tumor (2), bone (2), dorsal root ganglia (2), embryonic stem cell, retinoic acid andmitogen-treated hes cell line H7 (2), fetal eye (2), hepatocellular carcinoma (2), melanotic melanoma, cell line (2), ovarian tumor (2), pooled pancreas and spleen (2), pre-eclamptic placenta (2), renal carcinoma (ascites) (2), RPE and choroid (2), stomach normal (2), subchondral bone (2), adipose (once), adrenal cortico adenoma for cushing'ssyndrome (once), adrenal gland (once), alveolar macrophage (once), amygdala (once), astrocytoma (once), b-cells (once), brain glioblastoma (once), brain, astrocytoma, grade IV (once), breast (once), caudate nucleus (once), cell lines (once), cervical carcinoma cell line (once), cervix (once), chondrosarcoma (once), corpus callosum (once), denis drash (once), embryo, 8 weeks (once), embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells (once), epithelioid carcinoma (once), fetal muscle (abortion) (once), glioblastoma (pooled) (once), head normal (once), human embryonic stem cells differentiated toan early endodermal cell type (once), human lung epithelial cells (once), human retina (once), iris (once), lacrimal gland (once), leiomyosarcoma (once), liver and spleen (once), lymph node (once), lymphoma, follicular mixed small and largecell (once), metastatic chondrosarcoma (once), moderately-differentiated adenocarcinoma (once), moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors (once), muscle (once), neuroblastoma (once), normal prostatic epithelial cells (once), pectoral muscle (after mastectomy) (once), primary b-cells from tonsils (cell line) (once), prostate (once), prostate normal (once), renal cell adenocarcinoma (once), renal cell tumor (once), retina (once), rpe/choroid (once), serous papillary carcinoma, high grade, 2pooled tumors (once), spleen (once), synovial membrane tissue from rheumatioidarthritis (once), synovial membrane tissue from rheumatoidarthritis (once), tumor, 5 pooled (see description) (once), white matter (once).
309 cDNA clones support the 4 variants of gene ALDH2
?
This table helps analyze the pattern of expression of the gene, the tissue, cell type or disease state specificity of the alternative variants and to select cDNA clones suitable for your experiments.
cDNA accession Links to the sequence |
Tissue
most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features |
Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
NM_000690.2 | | .a | 1 to 2398 | 1 to 2398 | exact | RefSeq, AAA | | 2398/2398 (100 %) | 0 diff (100 %id) |
CB991970 | placenta, pre-eclamptic placenta | .a | 346 to 996 | 28 to 683 | | | | 656/834 (78 %) | 16 diff (98.1 %id) |
CB997156 | placenta, pre-eclamptic placenta | .a | 346 to 996 | 28 to 680 | | tiling clone, | | 653/856 (76 %) | 13 diff (98.5 %id) |
AL522212 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 357 to 1106 | 1 to 750 | | | | 750/750 (100 %) | 0 diff (100 %id) |
AL540170 | brain, fetal brain | .a | 357 to 1339 | 1 to 980 | | | | 980/980 (100 %) | 3 diff (99.7 %id) |
AY621070 | | .a | 381 to 2398 | 1 to 2018 | R116Q | | | 2018/2018 (100 %) | 2 diff (100.0 %id) |
BC127796 | PCR rescued clones, C list | .a | 383 to 1400 | 1020 to 3 | | | Submitted on the opposite strand | 1018/1029 (98 %) | 0 diff (100 %id) |
BI597143 | brain, hypothalamus | .a | 387 to 1242 | 1 to 868 | | | | 868/940 (92 %) | 33 diff (96.5 %id) |
TI_57239418 | | .a | 391 to 1068 | 30 to 707 | | | | 678/707 (95 %) | 6 diff (99.2 %id) |
TI_45214877 | | .a | 392 to 1083 | 89 to 779 | | | | 691/779 (88 %) | 11 diff (98.6 %id) |
TI_45216247 | | .a | 392 to 1242 | 129 to 991 | | | | 863/1063 (81 %) | 35 diff (96.8 %id) |
TI_45216317 | | .a | 392 to 1106 | 109 to 808 | | | | 700/1017 (68 %) | 18 diff (98.3 %id) |
TI_44346457 | | .a | 392 to 1230 | 76 to 920 | | | | 845/920 (91 %) | 33 diff (96.5 %id) |
TI_44346553 | | .a | 392 to 1242 | 82 to 939 | | | | 860/1001 (85 %) | 41 diff (96.0 %id) |
BI458297 | brain, hypothalamus | .a | 395 to 1203 | 1 to 818 | | | | 820/892 (91 %) | 30 diff (96.7 %id) |
BI668048 | brain, hypothalamus | .a | 395 to 1230 | 1 to 842 | | | | 842/842 (100 %) | 27 diff (96.8 %id) |
BI668144 | brain, hypothalamus | .a | 395 to 1242 | 1 to 855 | | | | 857/917 (93 %) | 40 diff (95.7 %id) |
BF725614 | eye, Iris | .a | 402 to 922 | 1 to 521 | | | | 521/521 (100 %) | 0 diff (100 %id) |
AL564795 | brain, fetal liver, Liver, neuroblastoma cells | .a | 402 to 1313 | 1 to 897 | | | | 897/921 (97 %) | 17 diff (98.2 %id) |
DB498200 | hypothalamus | .a | 403 to 896 | 1 to 494 | | | | 494/494 (100 %) | 0 diff (100 %id) |
DB505831 | hypothalamus | .a | 403 to 917 | 1 to 515 | | | | 515/515 (100 %) | 0 diff (100 %id) |
AK223373 | small intestine | .a | 404 to 2171 | 1 to 1768 | I65V | | | 1768/1768 (100 %) | 5 diff (99.8 %id) |
X05409 | fetal muscle (abortion) | .a | 406 to 2397 | 1 to 1989 | R7A F8R G9A R11P L12G ... | | | 1989/1989 (100 %) | 8 diff (99.6 %id) |
AL538754 | brain, fetal brain | .a | 408 to 1334 | 1 to 926 | | | | 926/926 (100 %) | 3 diff (99.7 %id) |
AL553428 | placenta, Placenta Cot 25-normalized | .a | 408 to 1343 | 1 to 929 | | | | 929/1043 (89 %) | 15 diff (98.6 %id) |
BG721446 | testis | .a | 408 to 1207 | 8 to 798 | | | | 791/799 (98 %) | 27 diff (96.7 %id) |
DB468417 | hippocampus | .a | 410 to 840 | 1 to 431 | | | | 431/431 (100 %) | 1 diff (99.8 %id) |
BU151478 | dorsal root ganglia | .a | 412 to 1074 | 1 to 665 | | | | 665/895 (74 %) | 3 diff (99.7 %id) |
Y00109 | muscle | .a | 412 to 2397 | 1 to 1980 | R7A F8W G9P P10A R11W ... | | | 1980/1980 (100 %) | 10 diff (99.5 %id) |
AL531568 | brain, fetal liver, Liver, neuroblastoma cells | .a | 413 to 1379 | 1 to 959 | | | | 959/1027 (93 %) | 12 diff (98.9 %id) |
BI914151 | brain | .a | 413 to 1251 | 1 to 840 | | | | 842/842 (100 %) | 20 diff (97.7 %id) |
TI_57147008 | | .a | 413 to 1143 | 21 to 748 | | | | 728/748 (97 %) | 8 diff (99.0 %id) |
TI_57242779 | | .a | 413 to 1251 | 29 to 868 | | | | 842/870 (96 %) | 23 diff (97.4 %id) |
BI599642 | brain, hypothalamus | .a | 416 to 1236 | 1 to 826 | | | | 826/842 (98 %) | 27 diff (96.8 %id) |
TI_45210790 | | .a | 417 to 1195 | 88 to 861 | | | | 774/861 (89 %) | 14 diff (98.4 %id) |
TI_45212908 | | .a | 417 to 1236 | 80 to 904 | | | | 825/920 (89 %) | 30 diff (96.8 %id) |
CR617194 | Placenta Cot 25-normalized | .a | 418 to 2348 | 1 to 1931 | exact | | | 1931/1931 (100 %) | 0 diff (100 %id) |
AL545610 | placenta, Placenta Cot 25-normalized | .a | 418 to 1343 | 1 to 927 | | | | 927/1085 (85 %) | 6 diff (99.5 %id) |
CX164387 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 418 to 1267 | 1 to 850 | | | | 850/850 (100 %) | 2 diff (99.8 %id) |
DB497715 | hypothalamus | .a | 419 to 911 | 1 to 493 | | | | 493/502 (98 %) | 2 diff (99.7 %id) |
DB505612 | hypothalamus | .a | 419 to 878 | 1 to 460 | | | | 460/460 (100 %) | 1 diff (99.8 %id) |
CD609384 | | .a | 421 to 666 | 257 to 12 | | | | 247/257 (96 %) | 4 diff (98.5 %id) |
DB505712 | hypothalamus | .a | 421 to 935 | 1 to 515 | | | | 515/515 (100 %) | 0 diff (100 %id) |
BU186773 | large cell carcinoma, lung | .a | 421 to 1207 | 1 to 793 | | | | 793/844 (93 %) | 13 diff (98.5 %id) |
DB454547 | testis | .a | 423 to 891 | 1 to 469 | | | | 469/469 (100 %) | 0 diff (100 %id) |
DB457478 | testis | .a | 423 to 885 | 1 to 463 | | | | 463/465 (99 %) | 3 diff (99.4 %id) |
DB502695 | hypothalamus | .a | 423 to 907 | 1 to 485 | | | | 485/485 (100 %) | 0 diff (100 %id) |
BQ881103 | dorsal root ganglia | .a | 423 to 1234 | 1 to 813 | | | | 813/858 (94 %) | 3 diff (99.7 %id) |
AK314856 | amygdala | .a | 424 to 1995 | 1 to 1571 | A48P K289R S290A N292T I293S ... | | | 1571/1571 (100 %) | 4 diff (99.8 %id) |
BG743241 | skin | .a | 425 to 1236 | 1 to 806 | | | | 806/876 (92 %) | 13 diff (98.6 %id) |
DB497261 | hypothalamus | .a | 428 to 917 | 1 to 490 | | | | 490/490 (100 %) | 1 diff (99.8 %id) |
TI_44343446 | | .a | 428 to 1137 | 126 to 838 | | | | 713/956 (74 %) | 21 diff (97.9 %id) |
DB482967 | hippocampus | .a | 430 to 935 | 1 to 505 | | | | 505/505 (100 %) | 1 diff (99.9 %id) |
AL532964 | adult brain, brain | .a | 432 to 1450 | 1 to 1006 | | | | 1006/1036 (97 %) | 28 diff (97.3 %id) |
BX420523 | brain, fetal brain | .a | 434 to 1439 | 1 to 994 | | | | 994/1035 (96 %) | 16 diff (98.5 %id) |
BG696292 | skin | .a | 435 to 1236 | 1 to 801 | | | | 801/817 (98 %) | 12 diff (98.6 %id) |
BI834562 | pooled pancreas and spleen | .a | 435 to 1236 | 1 to 801 | | | | 801/818 (97 %) | 10 diff (98.8 %id) |
TI_57167743 | | .a | 435 to 1236 | 49 to 849 | | | | 801/866 (92 %) | 16 diff (98.2 %id) |
BC071839 | Brain, astrocytoma, grade IV | .a | 437 to 2398 | 1 to 1962 | exact | tiling clone, available from MGC, AAA | | 1962/1962 (100 %) | 0 diff (100 %id) |
CD515435 | White Matter | .a | 438 to 1236 | 1 to 801 | | | | 801/876 (91 %) | 3 diff (99.7 %id) |
TI_1948145762 | | .a | 438 to 1233 | 125 to 921 | | | | 796/1247 (63 %) | 41 diff (96.8 %id) |
TI_1948146069 | | .a | 438 to 1137 | 121 to 829 | | | | 709/1374 (51 %) | 31 diff (97.8 %id) |
TI_1948146403 | | .a | 438 to 1123 | 125 to 811 | | | | 687/1290 (53 %) | 27 diff (98.0 %id) |
TI_1948146404 | | .a | 438 to 1339 | 120 to 1017 | | | | 898/1265 (70 %) | 29 diff (97.8 %id) |
TI_1948146714 | | .a | 438 to 1230 | 121 to 917 | | | | 797/1274 (62 %) | 39 diff (97.0 %id) |
TI_1948146715 | | .a | 438 to 1335 | 123 to 1022 | | | | 900/1294 (69 %) | 19 diff (98.6 %id) |
BX422479 | fetal liver, Liver | .a | 440 to 1313 | 1 to 872 | | | | 872/876 (99 %) | 13 diff (98.6 %id) |
BP420962 | small intestine | .a | 441 to 941 | 1 to 501 | | | Submitted on the opposite strand | 501/501 (100 %) | 0 diff (100 %id) |
CR456991 | | .a | 442 to 1995 | 1 to 1554 | S60F V362L | | | 1554/1554 (100 %) | 4 diff (99.8 %id) |
TI_57196277 | | .a | 455 to 1253 | 60 to 852 | | | | 793/852 (93 %) | 15 diff (98.3 %id) |
BE887478 | leiomyosarcoma, uterus | .a | 467 to 1125 | 1 to 658 | | | | 658/723 (91 %) | 8 diff (98.9 %id) |
AA001115 | eye, retina | .a | 474 to 538 | 1 to 64 | | | | 64/64 (100 %) | 3 diff (95.4 %id) |
CR620819 | Placenta Cot 25-normalized | .a | 491 to 2375 | 1 to 1885 | | | | 1885/1885 (100 %) | 0 diff (100 %id) |
AL548084 | placenta, Placenta Cot 25-normalized | .a | 491 to 1441 | 1 to 947 | | fully sequenced, | | 947/947 (100 %) | 5 diff (99.5 %id) |
CA397701 | eye, RPE/choroid | .a | 505 to 982 | 1 to 478 | | | | 478/478 (100 %) | 0 diff (100 %id) |
BF949405 | nervous_normal | .a | 526 to 953 | 1 to 451 | | | | 451/451 (100 %) | 43 diff (90.5 %id) |
CF272524 | Brain glioblastoma | .a | 537 to 1419 | 1 to 895 | | | | 895/902 (99 %) | 25 diff (97.3 %id) |
CD243709 | testis | .a | 545 to 1323 | 36 to 820 | | | | 785/936 (83 %) | 17 diff (98.2 %id) |
TI_59380729 | | .a | 553 to 1137 | 65 to 647 | | | | 583/691 (84 %) | 12 diff (98.3 %id) |
BQ083488 | stomach | .a | 560 to 1029 | 1 to 470 | | | | 470/470 (100 %) | 0 diff (100 %id) |
TI_227714757 | | .a | 570 to 1123 | 636 to 83 | | | | 555/1091 (50 %) | 1 diff (100.0 %id) |
BQ648251 | hepatocellular carcinoma, cell line, Liver | .a | 571 to 1447 | 23 to 899 | | | | 877/903 (97 %) | 18 diff (98.1 %id) |
BQ643713 | hepatocellular carcinoma, cell line, Liver | .a | 571 to 1435 | 25 to 896 | | | | 872/897 (97 %) | 19 diff (97.9 %id) |
BQ646098 | hepatocellular carcinoma, cell line, Liver | .a | 571 to 1388 | 18 to 841 | | | | 822/926 (88 %) | 20 diff (97.9 %id) |
BQ648302 | hepatocellular carcinoma, cell line, Liver | .a | 572 to 1249 | 1 to 678 | | | | 678/952 (71 %) | 2 diff (99.8 %id) |
BQ651870 | hepatocellular carcinoma, cell line, Liver | .a | 572 to 1323 | 1 to 757 | | | | 757/962 (78 %) | 17 diff (98.3 %id) |
BQ648143 | hepatocellular carcinoma, cell line, Liver | .a | 572 to 1390 | 1 to 826 | | | | 826/971 (85 %) | 27 diff (97.3 %id) |
BE272838 | Kidney, renal cell adenocarcinoma | .a | 604 to 880 | 1 to 277 | | | | 277/277 (100 %) | 0 diff (100 %id) |
CU448867 | epidermis | .a | 622 to 1348 | 13 to 739 | | | | 727/739 (98 %) | 6 diff (99.2 %id) |
CA406087 | adipose | .a | 638 to 794 | 6 to 162 | | | | 157/162 (96 %) | 11 diff (93.3 %id) |
BX488932 | | .a | 640 to 1225 | 1 to 586 | | | | 586/586 (100 %) | 0 diff (100 %id) |
BQ433381 | epithelioid carcinoma, Pancreas | .a | 646 to 1450 | 1 to 819 | | | | 818/902 (90 %) | 25 diff (97.3 %id) |
CR609508 | B cells (Ramos cell line) | .a | 659 to 2339 | 1 to 1681 | | | | 1681/1681 (100 %) | 0 diff (100 %id) |
AL559753 | B cells (Ramos cell line), B cells from Burkitt lymphoma | .a | 659 to 1524 | 1 to 865 | | | | 865/1019 (84 %) | 4 diff (99.7 %id) |
BQ708964 | Spleen | .a | 660 to 1504 | 19 to 872 | | | | 854/1028 (83 %) | 34 diff (96.7 %id) |
BM739192 | Ascites, stomach | .a | 660 to 1287 | 1 to 628 | | | | 628/628 (100 %) | 0 diff (100 %id) |
BG332061 | large cell carcinoma, lung | .a | 690 to 1528 | 1 to 837 | | | | 837/853 (98 %) | 38 diff (95.6 %id) |
TI_154185951 | | .a | 692 to 1528 | 99 to 922 | | | | 824/1065 (77 %) | 22 diff (98.0 %id) |
BQ925300 | large cell carcinoma, lung | .a | 693 to 1589 | 1 to 901 | | | | 901/964 (93 %) | 20 diff (98.0 %id) |
T08954 | | .a | 703 to 1047 | 1 to 345 | | | | 345/345 (100 %) | 0 diff (100 %id) |
DA429988 | colon | .a | 728 to 1289 | 2 to 563 | | capped | | 562/562 (100 %) | 0 diff (100 %id) |
BQ353667 | head_neck | .a | 794 to 1071 | 278 to 1 | | | | 278/282 (98 %) | 9 diff (96.9 %id) |
K03001 | Liver | .a | 796 to 2398 | 1 to 1603 | | | | 1603/1603 (100 %) | 1 diff (100.0 %id) |
M26760 | | .a | 796 to 1995 | 1 to 1200 | | | | 1200/1200 (100 %) | 1 diff (100.0 %id) |
BG757029 | B-cells, primary B-cells from tonsils (cell line) | .a | 804 to 1236 | 476 to 911 | | | | 436/957 (45 %) | 24 diff (97.5 %id) |
AA316218 | colon | .a | 819 to 1251 | 1 to 433 | | | | 433/433 (100 %) | 0 diff (100 %id) |
BQ338044 | nervous_normal | .a | 839 to 1122 | 307 to 21 | | | | 287/310 (92 %) | 3 diff (99.1 %id) |
CV334397 | nervous_tumor | .a | 874 to 1478 | 605 to 1 | | | Submitted on the opposite strand | 605/605 (100 %) | 0 diff (100 %id) |
CN484903 | eye | .a | 918 to 1541 | 1 to 624 | | | | 624/624 (100 %) | 0 diff (100 %id) |
BQ339279 | nervous_normal | .a | 951 to 1236 | 311 to 24 | | | | 288/311 (92 %) | 4 diff (98.8 %id) |
BU171977 | melanotic melanoma, cell line, skin | .a | 960 to 1686 | 1 to 731 | | | | 731/912 (80 %) | 7 diff (99.3 %id) |
BU174018 | melanotic melanoma, cell line, skin | .a | 967 to 1813 | 1 to 854 | | | | 854/912 (93 %) | 21 diff (97.7 %id) |
BM740979 | stomach | .a | 967 to 1479 | 1 to 513 | | | | 513/513 (100 %) | 0 diff (100 %id) |
BM746224 | stomach | .a | 967 to 1343 | 1 to 377 | | | | 377/381 (98 %) | 3 diff (99.3 %id) |
BM784297 | stomach | .a | 967 to 1621 | 1 to 655 | | | | 655/655 (100 %) | 0 diff (100 %id) |
BM784372 | stomach | .a | 967 to 1506 | 1 to 540 | | | | 540/540 (100 %) | 0 diff (100 %id) |
BM783506 | stomach | .a | 967 to 1669 | 1 to 703 | | | | 703/703 (100 %) | 0 diff (100 %id) |
BM765860 | stomach | .a | 967 to 1685 | 1 to 719 | | | | 719/719 (100 %) | 0 diff (100 %id) |
BM765605 | stomach | .a | 967 to 1339 | 1 to 373 | | | | 373/373 (100 %) | 0 diff (100 %id) |
BM765615 | stomach | .a | 967 to 1571 | 1 to 605 | | | | 605/605 (100 %) | 0 diff (100 %id) |
BM766085 | stomach | .a | 967 to 1500 | 1 to 534 | | | | 534/534 (100 %) | 0 diff (100 %id) |
BM765982 | stomach | .a | 967 to 1469 | 1 to 503 | | | | 503/503 (100 %) | 0 diff (100 %id) |
BM772876 | stomach | .a | 967 to 1619 | 1 to 653 | | | | 653/653 (100 %) | 0 diff (100 %id) |
BM773382 | stomach | .a | 967 to 1619 | 1 to 653 | | | | 653/653 (100 %) | 0 diff (100 %id) |
BG696274 | skin | .a | 998 to 1883 | 1 to 884 | | | | 876/884 (99 %) | 13 diff (98.6 %id) |
BP216360 | corpus callosum | .a | 1009 to 1583 | 1 to 575 | | | | 575/575 (100 %) | 0 diff (100 %id) |
TI_1948146406 | | .a | 1024 to 1994 | 1107 to 134 | | | | 974/1492 (65 %) | 51 diff (96.6 %id) |
TI_1948146716 | | .a | 1024 to 1994 | 1102 to 128 | | | | 975/1318 (73 %) | 30 diff (97.8 %id) |
CU456435 | epidermis | .a | 1043 to 1708 | 16 to 681 | | | | 666/681 (97 %) | 7 diff (99.0 %id) |
M54931 | Liver | .a | 1082 to 1941 | 1 to 861 | | | | 861/861 (100 %) | 13 diff (98.5 %id) |
AV650270 | corresponding non cancerous liver tissue | .a | 1118 to 1517 | 1 to 400 | | | Submitted on the opposite strand | 400/400 (100 %) | 0 diff (100 %id) |
AV650275 | corresponding non cancerous liver tissue | .a | 1118 to 1529 | 1 to 412 | | | Submitted on the opposite strand | 412/412 (100 %) | 0 diff (100 %id) |
AV650553 | corresponding non cancerous liver tissue | .a | 1118 to 1531 | 1 to 414 | | | Submitted on the opposite strand | 414/414 (100 %) | 0 diff (100 %id) |
TI_1948146717 | | .a | 1121 to 1994 | 1002 to 133 | | | | 870/1399 (62 %) | 16 diff (98.9 %id) |
BF569767 | Kidney, renal carcinoma (ascites) | .a | 1123 to 1689 | 1 to 565 | | fully sequenced, | | 565/565 (100 %) | 2 diff (99.7 %id) |
CD609387 | | .a | 1162 to 1803 | 640 to 1 | | | | 640/640 (100 %) | 5 diff (99.3 %id) |
CV334412 | nervous_tumor | .a | 1185 to 1478 | 294 to 1 | | | Submitted on the opposite strand | 294/294 (100 %) | 0 diff (100 %id) |
BQ324370 | colon_ins | .a | 1200 to 1522 | 393 to 68 | | | | 324/396 (81 %) | 7 diff (98.3 %id) |
BQ324900 | colon_ins | .a | 1206 to 1570 | 365 to 3 | | | | 363/365 (99 %) | 4 diff (99.0 %id) |
CD721913 | eye, lacrimal gland | .a | 1206 to 1825 | 1 to 620 | | | | 620/620 (100 %) | 0 diff (100 %id) |
BQ324348 | colon_ins | .a | 1207 to 1527 | 335 to 16 | | | | 323/336 (96 %) | 2 diff (99.5 %id) |
BQ324646 | colon_ins | .a | 1216 to 1510 | 38 to 333 | | | | 296/333 (88 %) | 16 diff (95.2 %id) |
CN258843 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 1225 to 1827 | 1 to 603 | | | | 603/603 (100 %) | 0 diff (100 %id) |
TI_1948145763 | | .a | 1227 to 1994 | 900 to 129 | | | | 772/1478 (52 %) | 11 diff (99.3 %id) |
BX410186 | adult brain, brain | .a | 1235 to 1667 | 1 to 432 | | | | 432/453 (95 %) | 17 diff (96.3 %id) |
BX410187 | adult brain, brain | .a | 1235 to 1525 | 1 to 290 | | | | 290/290 (100 %) | 9 diff (96.9 %id) |
TI_1948146071 | | .a | 1238 to 1994 | 885 to 130 | | | | 756/1463 (51 %) | 16 diff (99.0 %id) |
CD609388 | | .a | 1280 to 1944 | 671 to 8 | | | | 664/671 (98 %) | 3 diff (99.6 %id) |
BG428456 | Kidney | .a | 1281 to 2069 | 1 to 790 | | | | 790/790 (100 %) | 26 diff (96.8 %id) |
AA341219 | Kidney | .a | 1288 to 1456 | 1 to 169 | | | | 169/169 (100 %) | 0 diff (100 %id) |
AA332335 | Embryo, 8 weeks | .a | 1289 to 1446 | 1 to 158 | | | | 158/158 (100 %) | 0 diff (100 %id) |
BQ349656 | head_neck | .a | 1301 to 1695 | 458 to 56 | | | | 404/458 (88 %) | 7 diff (98.5 %id) |
BG740760 | skin | .a | 1306 to 2098 | 1 to 793 | | | | 793/794 (99 %) | 6 diff (99.3 %id) |
BM919125 | pooled pancreas and spleen | .a | 1326 to 2181 | 1 to 881 | | | | 881/1133 (77 %) | 38 diff (96.7 %id) |
AL545580 | placenta, Placenta Cot 25-normalized | .a | 1334 to 2348 | 1012 to 1 | | | | 1012/1200 (84 %) | 10 diff (99.2 %id) |
CB128990 | Liver | .a | 1340 to 1920 | 2 to 582 | | | | 581/582 (99 %) | 0 diff (100 %id) |
AL576537 | placenta, Placenta Cot 25-normalized | .a | 1342 to 2377 | 1021 to 1 | | | | 1021/1104 (92 %) | 23 diff (98.0 %id) |
AL564722 | brain, fetal liver, Liver, neuroblastoma cells | .a | 1342 to 2370 | 1026 to 1 | | | | 1026/1118 (91 %) | 10 diff (99.2 %id) |
AL568263 | brain, fetal brain | .a | 1345 to 2331 | 1024 to 39 | | | | 986/995 (99 %) | 15 diff (98.5 %id) |
AL532910 | adult brain, brain | .a | 1345 to 2370 | 1008 to 1 | | | | 1008/1008 (100 %) | 15 diff (98.6 %id) |
BM708164 | eye, RPE and Choroid | .a | 1350 to 1733 | 1 to 385 | | | | 385/385 (100 %) | 1 diff (99.8 %id) |
BI259438 | cervical carcinoma cell line, cervix | .a | 1390 to 2178 | 1 to 796 | | | | 796/797 (99 %) | 12 diff (98.5 %id) |
BM729983 | insulinoma, Pancreas | .a | 1394 to 1971 | 1 to 578 | | | | 578/578 (100 %) | 5 diff (99.2 %id) |
CK823916 | insulinoma, Pancreas | .a | 1394 to 1957 | 1 to 564 | | | | 564/564 (100 %) | 5 diff (99.2 %id) |
AI907063 | breast | .a | 1399 to 1914 | 71 to 585 | | | | 515/595 (86 %) | 8 diff (98.7 %id) |
AL548048 | placenta, Placenta Cot 25-normalized | .a | 1411 to 2375 | 965 to 1 | | fully sequenced, | | 963/963 (100 %) | 23 diff (97.7 %id) |
CN258840 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 1428 to 1877 | 1 to 450 | | | | 450/450 (100 %) | 0 diff (100 %id) |
BQ318005 | colon | .a | 1431 to 1692 | 270 to 6 | | | | 267/277 (96 %) | 2 diff (99.3 %id) |
AL538753 | brain, fetal brain | .a | 1435 to 2368 | 931 to 1 | | | | 931/931 (100 %) | 14 diff (98.5 %id) |
TI_45236110 | | .a | 1448 to 2272 | 69 to 900 | | fully sequenced, AAA | | 832/900 (92 %) | 17 diff (98.2 %id) |
FN130001 | breast carcinoma | .a | 1449 to 1556 | 105 to 1 | | | Submitted on the opposite strand | 105/111 (94 %) | 5 diff (95.5 %id) |
BM853466 | Ascites, stomach | .a | 1495 to 1962 | 1 to 468 | | | | 468/468 (100 %) | 0 diff (100 %id) |
BM721621 | eye, fetal eye | .a | 1502 to 1896 | 1 to 393 | | | | 393/393 (100 %) | 4 diff (99.0 %id) |
AL581304 | B cells (Ramos cell line), B cells from Burkitt lymphoma | .a | 1518 to 2339 | 821 to 1 | | | | 821/985 (83 %) | 30 diff (97.0 %id) |
TI_149293213 | | .a | 1518 to 2398 | 962 to 84 | | AAA | | 879/997 (88 %) | 12 diff (98.8 %id) |
AL531567 | brain, fetal liver, Liver, neuroblastoma cells | .a | 1522 to 2340 | 851 to 33 | | | | 819/824 (99 %) | 3 diff (99.7 %id) |
TI_149297071 | | .a | 1528 to 2398 | 949 to 86 | | AAA | | 864/943 (91 %) | 8 diff (99.2 %id) |
TI_149303913 | | .a | 1528 to 2398 | 938 to 81 | | AAA | | 858/945 (90 %) | 17 diff (98.3 %id) |
TI_149309002 | | .a | 1528 to 2403 | 954 to 86 | | AAA | | 869/978 (88 %) | 11 diff (98.9 %id) |
BM702136 | eye, optic nerve | .a | 1554 to 1993 | 1 to 440 | | fully sequenced, | | 440/440 (100 %) | 0 diff (100 %id) |
BM702187 | eye, optic nerve | .a | 1554 to 1993 | 1 to 437 | | fully sequenced, | | 437/437 (100 %) | 0 diff (100 %id) |
BQ353001 | head_neck | .a | 1564 to 1908 | 348 to 4 | | | | 345/348 (99 %) | 0 diff (100 %id) |
AL522211 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 1565 to 2385 | 819 to 1 | | | | 819/819 (100 %) | 19 diff (97.7 %id) |
BQ350772 | head_neck | .a | 1570 to 1848 | 288 to 6 | | | | 283/288 (98 %) | 0 diff (100 %id) |
TI_151769386 | | .a | 1574 to 2163 | 110 to 701 | | | | 592/985 (60 %) | 28 diff (97.2 %id) |
TI_149303857 | | .a | 1578 to 2398 | 890 to 74 | | AAA | | 817/943 (86 %) | 10 diff (99.0 %id) |
BQ339646 | nervous_normal | .a | 1584 to 1686 | 116 to 15 | | | | 102/116 (87 %) | 0 diff (100 %id) |
AW869777 | stomach_normal | .a | 1590 to 1769 | 198 to 18 | | | | 179/205 (87 %) | 1 diff (99.6 %id) |
BQ364637 | stomach_normal | .a | 1590 to 1773 | 184 to 1 | | | | 184/191 (96 %) | 3 diff (98.5 %id) |
TI_149301992 | | .a | 1593 to 2398 | 892 to 90 | | AAA | | 803/939 (85 %) | 8 diff (99.2 %id) |
BE259405 | brain, neuroblastoma | .a | 1603 to 2390 | 1 to 786 | | | | 786/787 (99 %) | 20 diff (97.5 %id) |
BM982203 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 1608 to 2398 | 808 to 19 | | AAA | | 790/790 (100 %) | 2 diff (99.8 %id) |
BU626457 | Alveolar Macrophage, lung | .a | 1608 to 2398 | 808 to 19 | | AAA | | 790/790 (100 %) | 1 diff (99.9 %id) |
TI_149314922 | | .a | 1613 to 2405 | 867 to 84 | | tiling clone, AAA | | 784/972 (80 %) | 11 diff (98.9 %id) |
AV647132 | corresponding non cancerous liver tissue | .a | 1624 to 2062 | 1 to 439 | | | Submitted on the opposite strand | 439/439 (100 %) | 0 diff (100 %id) |
CB851098 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 1630 to 2398 | 787 to 19 | | AAA | | 769/769 (100 %) | 1 diff (99.9 %id) |
AA419133 | ovarian tumor, ovary | .a | 1631 to 1993 | 6 to 368 | | fully sequenced, | | 363/368 (98 %) | 7 diff (98.1 %id) |
BM980181 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 1631 to 2398 | 785 to 19 | | AAA | | 767/767 (100 %) | 2 diff (99.8 %id) |
BQ315615 | colon | .a | 1634 to 1905 | 272 to 1 | | | | 272/272 (100 %) | 4 diff (98.6 %id) |
AV653398 | corresponding non cancerous liver tissue | .a | 1640 to 2062 | 1 to 423 | | | Submitted on the opposite strand | 423/423 (100 %) | 0 diff (100 %id) |
CU445131 | epidermis | .a | 1641 to 2152 | 524 to 13 | | | Submitted on the opposite strand | 512/524 (97 %) | 0 diff (100 %id) |
BQ315616 | colon | .a | 1646 to 1905 | 260 to 1 | | | | 260/260 (100 %) | 2 diff (99.3 %id) |
AW862315 | colon | .a | 1648 to 1849 | 220 to 20 | | | | 202/220 (91 %) | 0 diff (100 %id) |
BQ362168 | stomach | .a | 1648 to 1905 | 258 to 1 | | | | 258/258 (100 %) | 2 diff (99.3 %id) |
BF570286 | Kidney, renal carcinoma (ascites) | .a | 1659 to 2349 | 693 to 1 | | fully sequenced, | | 693/693 (100 %) | 5 diff (99.3 %id) |
BU687348 | lung | .a | 1663 to 2403 | 759 to 19 | | AAA | | 741/741 (100 %) | 1 diff (99.9 %id) |
CN258844 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 1668 to 2213 | 1 to 546 | | | | 546/546 (100 %) | 0 diff (100 %id) |
BQ319167 | colon | .a | 1676 to 2112 | 437 to 1 | | | | 437/437 (100 %) | 18 diff (95.9 %id) |
BM782514 | Ascites, stomach | .a | 1679 to 2276 | 1 to 598 | | | | 598/598 (100 %) | 0 diff (100 %id) |
FN101162 | breast carcinoma | .a | 1687 to 1746 | 1 to 60 | | | | 60/61 (98 %) | 1 diff (98.4 %id) |
BM993788 | Bone, Subchondral Bone | .a | 1690 to 2398 | 727 to 19 | | AAA | | 709/709 (100 %) | 3 diff (99.6 %id) |
CN479669 | Bone, Subchondral Bone | .a | 1690 to 2398 | 727 to 19 | | AAA | | 709/709 (100 %) | 3 diff (99.6 %id) |
BU607893 | Human Lung Epithelial cells, lung | .a | 1700 to 2398 | 717 to 19 | | AAA | | 699/699 (100 %) | 1 diff (99.9 %id) |
CU444501 | epidermis | .a | 1720 to 2216 | 502 to 7 | | | Submitted on the opposite strand | 496/506 (98 %) | 2 diff (99.7 %id) |
BM852361 | Ascites, stomach | .a | 1720 to 2172 | 1 to 453 | | | | 453/453 (100 %) | 0 diff (100 %id) |
BQ347284 | head_neck | .a | 1722 to 1905 | 184 to 1 | | | | 184/184 (100 %) | 0 diff (100 %id) |
CU443840 | epidermis | .a | 1726 to 2152 | 427 to 1 | | | Submitted on the opposite strand | 427/427 (100 %) | 5 diff (98.9 %id) |
BM784026 | Ascites, stomach | .a | 1729 to 2370 | 1 to 642 | | | | 642/642 (100 %) | 2 diff (99.7 %id) |
BQ362166 | stomach | .a | 1730 to 1905 | 176 to 1 | | | | 176/176 (100 %) | 0 diff (100 %id) |
BI039745 | nervous_tumor | .a | 1745 to 1919 | 190 to 4 | | | | 187/195 (95 %) | 18 diff (90.8 %id) |
CU443695 | epidermis | .a | 1749 to 2359 | 625 to 16 | | | Submitted on the opposite strand | 610/634 (96 %) | 3 diff (99.6 %id) |
CU444621 | epidermis | .a | 1749 to 2366 | 625 to 10 | | | Submitted on the opposite strand | 616/634 (97 %) | 4 diff (99.4 %id) |
CU449414 | epidermis | .a | 1749 to 2366 | 626 to 10 | | | Submitted on the opposite strand | 617/635 (97 %) | 3 diff (99.6 %id) |
CU455830 | epidermis | .a | 1749 to 2366 | 626 to 10 | | | Submitted on the opposite strand | 617/635 (97 %) | 3 diff (99.6 %id) |
CU457067 | epidermis | .a | 1749 to 2366 | 626 to 10 | | | Submitted on the opposite strand | 617/635 (97 %) | 3 diff (99.6 %id) |
FN139212 | breast carcinoma | .a | 1764 to 1833 | 1 to 70 | | | | 70/71 (98 %) | 1 diff (98.6 %id) |
CB163633 | Liver | .a | 1777 to 2388 | 611 to 1 | | | Submitted on the opposite strand | 611/611 (100 %) | 1 diff (99.9 %id) |
CV351492 | prostate_normal | .a | 1790 to 2358 | 569 to 2 | | | Submitted on the opposite strand | 568/569 (99 %) | 2 diff (99.7 %id) |
AI889135 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .a | 1791 to 2398 | 634 to 28 | | AAA | | 607/607 (100 %) | 4 diff (99.4 %id) |
BI492481.
matches multiple genes | cochlea, ear | .a | 1795 to 2398 | 622 to 19 | | AAA | also hits gene SLC35F1 | 604/608 (99 %) | 1 diff (99.9 %id) |
BM511646 | insulinoma, Pancreas | .a | 1795 to 2403 | 626 to 18 | | AAA | | 609/609 (100 %) | 0 diff (100 %id) |
BE169011 | head_neck | .a | 1807 to 1914 | 1 to 109 | | | | 109/110 (99 %) | 11 diff (90.0 %id) |
BF737267 | bladder_tumor | .a | 1807 to 2188 | 386 to 5 | | | Submitted on the opposite strand | 382/386 (98 %) | 9 diff (97.7 %id) |
AW662438 | colon, moderately-differentiated adenocarcinoma | .a | 1808 to 1990 | 183 to 1 | | | | 183/190 (96 %) | 9 diff (95.3 %id) |
TI_45236111 | | .a | 1817 to 2204 | 406 to 17 | | fully sequenced, | | 390/406 (96 %) | 2 diff (99.6 %id) |
AV655003 | corresponding non cancerous liver tissue | .a | 1820 to 2228 | 1 to 356 | | | Submitted on the opposite strand | 356/356 (100 %) | 30 diff (91.6 %id) |
BM992703 | lung, Metastatic Chondrosarcoma | .a | 1820 to 2398 | 597 to 19 | | AAA | | 579/579 (100 %) | 0 diff (100 %id) |
BU732011 | eye, RPE and Choroid | .a | 1820 to 2398 | 597 to 19 | | AAA | | 579/579 (100 %) | 3 diff (99.5 %id) |
BP419702 | small intestine | .a | 1829 to 2275 | 1 to 447 | | | Submitted on the opposite strand | 447/447 (100 %) | 0 diff (100 %id) |
AI460073 | astrocytoma, brain | .a | 1831 to 2234 | 404 to 1 | | | | 404/404 (100 %) | 0 diff (100 %id) |
DB577125 | hypothalamus | .a | 1842 to 2340 | 1 to 499 | | | Submitted on the opposite strand | 499/499 (100 %) | 0 diff (100 %id) |
AI499010 | anaplastic oligodendroglioma, brain | .a | 1843 to 2398 | 556 to 1 | | | | 556/556 (100 %) | 0 diff (100 %id) |
BF964297 | nervous_normal | .a | 1879 to 2239 | 413 to 60 | | | | 357/413 (86 %) | 4 diff (99.1 %id) |
DB569293 | hypothalamus | .a | 1883 to 2340 | 1 to 458 | | | Submitted on the opposite strand | 458/458 (100 %) | 0 diff (100 %id) |
AI090447 | heart | .a | 1894 to 2398 | 505 to 1 | | | | 505/505 (100 %) | 0 diff (100 %id) |
BF826694 | head_normal | .a | 1898 to 2263 | 368 to 1 | | | Submitted on the opposite strand | 368/368 (100 %) | 7 diff (98.1 %id) |
FN126138 | breast carcinoma | .a | 1898 to 1998 | 1 to 101 | | | | 101/101 (100 %) | 0 diff (100 %id) |
AI146792 | heart | .a | 1912 to 2399 | 488 to 1 | | | | 488/488 (100 %) | 0 diff (100 %id) |
AA805610 | germinal center B cell | .a | 1917 to 2398 | 499 to 19 | | AAA | | 481/483 (99 %) | 11 diff (97.8 %id) |
DB576894 | hypothalamus | .a | 1918 to 2405 | 1 to 488 | | | Submitted on the opposite strand | 488/488 (100 %) | 0 diff (100 %id) |
BM695868 | eye, human retina | .a | 1920 to 2189 | 1 to 270 | | | | 270/270 (100 %) | 0 diff (100 %id) |
BU732519 | eye, optic nerve | .a | 1920 to 2403 | 502 to 19 | | AAA | | 484/484 (100 %) | 0 diff (100 %id) |
AI160133 | brain, glioblastoma (pooled) | .a | 1921 to 2400 | 480 to 1 | | | | 480/480 (100 %) | 0 diff (100 %id) |
DB568814 | hypothalamus | .a | 1927 to 2405 | 1 to 479 | | | Submitted on the opposite strand | 479/479 (100 %) | 0 diff (100 %id) |
BM677229 | eye, fetal eye | .a | 1931 to 2398 | 485 to 19 | | AAA | | 467/467 (100 %) | 4 diff (99.2 %id) |
C75356 | | .a | 1932 to 2404 | 486 to 9 | | | | 478/486 (98 %) | 1 diff (99.8 %id) |
AA419072 | ovarian tumor, ovary | .a | 1932 to 2399 | 467 to 1 | | fully sequenced, | | 467/467 (100 %) | 0 diff (100 %id) |
BM664828 | eye, optic nerve | .a | 1932 to 2398 | 485 to 19 | | fully sequenced, AAA | | 467/467 (100 %) | 0 diff (100 %id) |
BM664881 | eye, optic nerve | .a | 1932 to 2398 | 486 to 19 | | fully sequenced, AAA | | 468/468 (100 %) | 5 diff (99.0 %id) |
DB551827 | hippocampus | .a | 1934 to 2398 | 1 to 465 | | | Submitted on the opposite strand | 465/465 (100 %) | 1 diff (99.8 %id) |
F37029 | pectoral muscle (after mastectomy) | .a | 1943 to 2310 | 1 to 368 | | | | 368/368 (100 %) | 0 diff (100 %id) |
AL043849 | testis | .a | 1949 to 2398 | 1 to 450 | | fully sequenced, AAA | | 450/450 (100 %) | 0 diff (100 %id) |
FN049123 | breast carcinoma | .a | 1949 to 2041 | 93 to 1 | | | Submitted on the opposite strand | 93/93 (100 %) | 0 diff (100 %id) |
DB568312 | hypothalamus | .a | 1949 to 2400 | 1 to 452 | | | Submitted on the opposite strand | 452/457 (98 %) | 1 diff (99.8 %id) |
BM986820 | mixed | .a | 1951 to 2403 | 471 to 19 | | AAA | | 453/453 (100 %) | 0 diff (100 %id) |
DB573923 | hypothalamus | .a | 1961 to 2403 | 1 to 444 | | AAA | Submitted on the opposite strand | 444/444 (100 %) | 3 diff (99.4 %id) |
BP430017 | | .a | 1961 to 2367 | 1 to 407 | | | | 407/407 (100 %) | 0 diff (100 %id) |
BP430561 | | .a | 1961 to 2339 | 1 to 379 | | | | 379/379 (100 %) | 0 diff (100 %id) |
FN143820 | breast carcinoma | .a | 1963 to 2040 | 15 to 91 | | | | 77/91 (84 %) | 6 diff (93.5 %id) |
BI497015 | cochlea, ear | .a | 1963 to 2398 | 1 to 437 | | AAA | | 437/437 (100 %) | 5 diff (98.9 %id) |
S80262 | | .a | 1963 to 2190 | 182 to 410 | | | | 229/410 (55 %) | 1 diff (99.8 %id) |
AW105496 | ovary, tumor, 5 pooled (see description) | .a | 1967 to 2398 | 432 to 1 | | | | 432/432 (100 %) | 0 diff (100 %id) |
DB522953 | testis | .a | 1968 to 2398 | 1 to 431 | | AAA | Submitted on the opposite strand | 431/431 (100 %) | 2 diff (99.6 %id) |
AI272886 | adenocarcinoma, colon | .a | 1968 to 2398 | 431 to 1 | | | | 431/431 (100 %) | 0 diff (100 %id) |
AA830815 | germinal center B cell | .a | 1970 to 2398 | 473 to 45 | | AAA | | 429/429 (100 %) | 0 diff (100 %id) |
BM760986 | Ascites, stomach | .a | 1974 to 2398 | 1 to 425 | | AAA | | 425/425 (100 %) | 0 diff (100 %id) |
AA677335 | liver and spleen | .a | 1977 to 2403 | 427 to 1 | | | | 427/427 (100 %) | 0 diff (100 %id) |
DB535678 | hippocampus | .a | 1982 to 2398 | 1 to 418 | | AAA | Submitted on the opposite strand | 418/418 (100 %) | 5 diff (98.9 %id) |
AA548678 | normal prostatic epithelial cells, Prostate | .a | 2008 to 2402 | 395 to 1 | | | | 395/395 (100 %) | 0 diff (100 %id) |
AV655407 | corresponding non cancerous liver tissue | .a | 2012 to 2403 | 1 to 392 | | AAA | Submitted on the opposite strand | 392/392 (100 %) | 0 diff (100 %id) |
AA715095 | germinal center B cell | .a | 2013 to 2398 | 396 to 11 | | AAA | | 386/386 (100 %) | 0 diff (100 %id) |
AA923050 | Kidney | .a | 2035 to 2398 | 364 to 1 | | | | 364/364 (100 %) | 0 diff (100 %id) |
AW384420 | head_neck | .a | 2045 to 2348 | 312 to 9 | | | | 304/318 (95 %) | 0 diff (100 %id) |
AI354279 | Kidney, renal cell tumor | .a | 2052 to 2398 | 360 to 14 | | AAA | | 347/347 (100 %) | 0 diff (100 %id) |
FN124363 | breast carcinoma | .a | 2056 to 2139 | 1 to 82 | | | | 82/83 (98 %) | 3 diff (96.4 %id) |
AI568300 | lymph node, lymphoma, follicular mixed small and largecell | .a | 2057 to 2403 | 357 to 11 | | AAA | | 347/347 (100 %) | 0 diff (100 %id) |
AI186384 | heart | .a | 2058 to 2398 | 357 to 17 | | AAA | | 341/341 (100 %) | 0 diff (100 %id) |
CA424936 | cell lines, Chondrosarcoma | .a | 2058 to 2398 | 359 to 19 | | AAA | | 341/341 (100 %) | 0 diff (100 %id) |
FN056677 | breast carcinoma | .a | 2059 to 2155 | 97 to 1 | | | Submitted on the opposite strand | 97/98 (98 %) | 0 diff (100 %id) |
AI350206 | carcinoid, lung | .a | 2062 to 2397 | 336 to 1 | | | | 336/336 (100 %) | 0 diff (100 %id) |
BY999331 | | .a | 2068 to 2334 | 1 to 266 | | | Submitted on the opposite strand | 266/332 (80 %) | 6 diff (98.2 %id) |
FN141185 | breast carcinoma | .a | 2073 to 2153 | 81 to 1 | | | Submitted on the opposite strand | 81/82 (98 %) | 1 diff (98.8 %id) |
AW188884 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 2079 to 2403 | 325 to 1 | | | | 325/325 (100 %) | 0 diff (100 %id) |
FN049120 | breast carcinoma | .a | 2082 to 2204 | 123 to 1 | | | Submitted on the opposite strand | 123/123 (100 %) | 0 diff (100 %id) |
BG056829 | anaplastic oligodendroglioma, brain | .a | 2089 to 2399 | 311 to 1 | | | | 311/311 (100 %) | 0 diff (100 %id) |
AA995393 | carcinoid, lung | .a | 2097 to 2397 | 301 to 1 | | | | 301/301 (100 %) | 0 diff (100 %id) |
FN091539 | breast carcinoma | .a | 2115 to 2197 | 1 to 79 | | | | 79/86 (91 %) | 4 diff (95.4 %id) |
AI261830 | Kidney | .a | 2149 to 2398 | 250 to 1 | | | | 250/250 (100 %) | 0 diff (100 %id) |
GD160024 | | .a | 2161 to 2402 | 9 to 260 | | AAA | | 252/260 (96 %) | 9 diff (96.6 %id) |
AL043850 | testis | .a | 2165 to 2389 | 225 to 1 | | fully sequenced, | | 225/225 (100 %) | 0 diff (100 %id) |
BF754711 | colon | .a | 2184 to 2324 | 141 to 2 | | | Submitted on the opposite strand | 140/144 (97 %) | 0 diff (100 %id) |
AA973381 | carcinoid, lung | .a | 2193 to 2397 | 205 to 1 | | | | 205/205 (100 %) | 0 diff (100 %id) |
T72070 | Liver | .a | 2204 to 2380 | 177 to 1 | | | | 177/177 (100 %) | 0 diff (100 %id) |
AI865937 | adenocarcinoma, Pancreas | .a | 2211 to 2398 | 198 to 11 | | AAA | | 188/188 (100 %) | 0 diff (100 %id) |
AV712260 | | .a | 2222 to 2396 | 1 to 175 | | AAA | | 175/175 (100 %) | 0 diff (100 %id) |
CD014082 | | .b | 1 to 1760 | 1 to 1760 | V321F | tiling clone, | | 1760/1760 (100 %) | 1 diff (100.0 %id) |
AV653329 | corresponding non cancerous liver tissue | .b | 1322 to 1947 | 1 to 626 | | tiling clone, | Submitted on the opposite strand | 635/636 (99 %) | 4 diff (99.4 %id) |
DC353712 | brain | .c | 1 to 581 | 1 to 581 | | tiling clone, | | 581/581 (100 %) | 1 diff (99.9 %id) |
BP218054 | caudate nucleus | .c | 47 to 629 | 1 to 583 | | | | 583/583 (100 %) | 4 diff (99.4 %id) |
AK301375 | synovial membrane tissue from rheumatoidarthritis | .c | 63 to 1572 | 1 to 1510 | Y285C | tiling clone, | | 1510/1510 (100 %) | 2 diff (99.9 %id) |
DC295251 | synovial membrane tissue from rheumatioidarthritis | .c | 63 to 607 | 1 to 545 | | | | 545/545 (100 %) | 1 diff (99.9 %id) |
BP349729 | brain | .c | 71 to 655 | 1 to 581 | | tiling clone, | | 581/582 (99 %) | 9 diff (98.5 %id) |
CR618953 | Neuroblastoma Cot 10-normalized | .d | 1 to 1764 | 1 to 1764 | exact | tiling clone, | | 1764/1764 (100 %) | 0 diff (100 %id) |
AV711398 | adrenal cortico adenoma for Cushing'ssyndrome | .d | 1632 to 2022 | 58 to 448 | | tiling clone, | | 391/448 (87 %) | 6 diff (98.7 %id) |
AV707850 | adrenal gland | Gene ALDH2, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
AW939694 | denis_drash | Gene ALDH2, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
BF737934 | bladder_tumor | Gene ALDH2, variant not shown | | | | | This clone was ignored | | |
AL521489 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | Gene ALDH2, variant not shown | | | | fully sequenced, | Suspected internal deletion, this clone was ignored | | |
AL521490 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | Gene ALDH2, variant not shown | | | | fully sequenced, | Suspected internal deletion, this clone was ignored | | |
CU447847 | epidermis | Gene ALDH2, variant not shown | | | | | Submitted on the opposite strand | | |
CV375645 | nervous_normal | Gene ALDH2, variant not shown | | | | | Submitted on the opposite strand | | |
AV684344 | hepatocellular carcinoma | Gene ALDH2, variant not shown | | | | | This clone was ignored | | |
AV693532 | hepatocellular carcinoma | Gene ALDH2, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
AV662302 | corresponding non cancerous liver tissue | Gene ALDH2, variant not shown | | | | AAA | Submitted on the opposite strand, submitted on the opposite strand | | |
AW020236 | cochlea, ear | Gene ALDH2, variant not shown | | | | fully sequenced, | This clone was ignored | | |
BI491284 | cochlea, ear | Gene ALDH2, variant not shown | | | | fully sequenced, | This clone was ignored | | |
TI_1948146405 | | Gene ALDH2, variant not shown | | | | | This clone was ignored | | |
TI_149304086 | | Gene ALDH2, variant not shown | | | | AAA | This clone was ignored | | |
BM981965 | lung, Primary Lung Cystic Fibrosis EpithelialCells | Gene ALDH2, variant not shown | | | | AAA | This clone was ignored | | |
To mine knowledge about the gene, please click the 'Gene Summary' or the 'Function, regulation, related genes ' tab at the top of the page. The 'Gene Summary' page includes all we learnt about the gene, functional annotations of neighboring genes, maps, links to other sites and the bibliography. The 'Function, regulation, related genes ' page includes Diseases (D), Pathways, GO annotations, conserved domains (C), interactions (I) reference into function, and pointers to all genes with the same functional annotation.
To compare alternative variants, their summarized annotations, predicted proteins, introns and exons, or to access any sequence, click the 'Alternative mRNAs features' tab. To see a specific mRNA variant diagram, sequence and annotation, click the variant name in the 'mRNA' tab. To examine expression data from all cDNAs clustered in this gene by AceView, click the 'Expression tissue'.
If you know more about this gene, or found errors, please share your knowledge. Thank you !